> top > docs > PMC:7499532 > annotations

PMC:7499532 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 187-189 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898
T2 387-389 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 105-113 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 320-328 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T3 331-340 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T4 345-353 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 507-515 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 545-553 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T7 889-897 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 960-968 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1059-1067 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 13-14 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 66-67 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 268-269 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 505-506 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 638-639 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 806-811 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T7 958-959 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T8 1012-1017 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T9 1096-1097 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 105-113 Disease denotes COVID-19 MESH:C000657245
9 545-555 Species denotes SARS-CoV-2 Tax:2697049
10 889-899 Species denotes SARS-CoV-2 Tax:2697049
11 1059-1069 Species denotes SARS-CoV-2 Tax:2697049
12 320-340 Disease denotes SARS-CoV-2 infection MESH:C000657245
13 345-353 Disease denotes COVID-19 MESH:C000657245
14 507-515 Disease denotes COVID-19 MESH:C000657245
15 960-968 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-135 Sentence denotes Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers
T2 137-145 Sentence denotes Abstract
T3 146-154 Sentence denotes Abstract
T4 155-382 Sentence denotes WHO convened an Advisory Group (AG) to consider the feasibility, potential value and limitations of establishing a closely-monitored challenge model of experimental SARS-CoV-2 infection and COVID-19 in healthy adult volunteers.
T5 383-462 Sentence denotes The AG included experts in design, establishment and performance of challenges.
T6 463-957 Sentence denotes This report summarizes issues that render a COVID-19 model daunting to establish (SARS-CoV-2’s potential to cause severe/fatal illness, its high transmissibility, and lack of a “rescue treatment” to prevent progression from mild/moderate to severe clinical illness) and it proffers prudent strategies for stepwise model development, challenge virus selection, guidelines for manufacturing challenge doses, and ways to contain SARS-CoV-2 and prevent transmission to household/community contacts.
T7 958-1095 Sentence denotes A COVID-19 model could demonstrate protection against virus shedding and/or illness induced by prior SARS-CoV-2 challenge or vaccination.
T8 1096-1275 Sentence denotes A limitation of the model is that vaccine efficacy in experimentally challenged healthy young adults cannot per se be extrapolated to predict efficacy in elderly/high-risk adults.